NO972725D0 - Spraytörket erytroprotein - Google Patents

Spraytörket erytroprotein

Info

Publication number
NO972725D0
NO972725D0 NO972725A NO972725A NO972725D0 NO 972725 D0 NO972725 D0 NO 972725D0 NO 972725 A NO972725 A NO 972725A NO 972725 A NO972725 A NO 972725A NO 972725 D0 NO972725 D0 NO 972725D0
Authority
NO
Norway
Prior art keywords
spray
erythroprotein
dried
rhepo
provides
Prior art date
Application number
NO972725A
Other languages
English (en)
Other versions
NO972725L (no
NO319895B1 (no
Inventor
Deepak B Mehta
Diane Corbo
Khursid Iqbal
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23407689&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO972725(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of NO972725D0 publication Critical patent/NO972725D0/no
Publication of NO972725L publication Critical patent/NO972725L/no
Publication of NO319895B1 publication Critical patent/NO319895B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
NO19972725A 1994-12-16 1997-06-13 Fremgangsmate for fremstilling av spraytorket rhEPO, samt torr rhEPO fremsatt i henhold til denne metoden og sammensetning derav. NO319895B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35794794A 1994-12-16 1994-12-16
PCT/US1995/016416 WO1996018647A1 (en) 1994-12-16 1995-12-15 Spray dried erythropoietin

Publications (3)

Publication Number Publication Date
NO972725D0 true NO972725D0 (no) 1997-06-13
NO972725L NO972725L (no) 1997-08-06
NO319895B1 NO319895B1 (no) 2005-09-26

Family

ID=23407689

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972725A NO319895B1 (no) 1994-12-16 1997-06-13 Fremgangsmate for fremstilling av spraytorket rhEPO, samt torr rhEPO fremsatt i henhold til denne metoden og sammensetning derav.

Country Status (19)

Country Link
US (2) US6001800A (no)
EP (1) EP0805822B2 (no)
JP (1) JP4039686B2 (no)
CN (1) CN1117762C (no)
AT (1) ATE265468T1 (no)
AU (1) AU697287B2 (no)
CA (1) CA2207615C (no)
DE (1) DE69532970T3 (no)
DK (1) DK0805822T4 (no)
ES (1) ES2219672T5 (no)
FI (1) FI119723B (no)
HU (1) HU222370B1 (no)
IL (1) IL116085A (no)
NO (1) NO319895B1 (no)
NZ (1) NZ298981A (no)
PT (1) PT805822E (no)
TW (1) TW425287B (no)
WO (1) WO1996018647A1 (no)
ZA (1) ZA9510708B (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
US6081536A (en) 1997-06-20 2000-06-27 Tantivy Communications, Inc. Dynamic bandwidth allocation to transmit a wireless protocol across a code division multiple access (CDMA) radio link
US6542481B2 (en) 1998-06-01 2003-04-01 Tantivy Communications, Inc. Dynamic bandwidth allocation for multiple access communication using session queues
US6151332A (en) 1997-06-20 2000-11-21 Tantivy Communications, Inc. Protocol conversion and bandwidth reduction technique providing multiple nB+D ISDN basic rate interface links over a wireless code division multiple access communication system
EP0913177A1 (de) * 1997-11-03 1999-05-06 Roche Diagnostics GmbH Verfahren zur Herstellung trockener, amorpher Produkte enthaltend biologisch aktive Materialien mittels Konvektionstrocknung, insbesondere Sprühtrocknung
US7936728B2 (en) 1997-12-17 2011-05-03 Tantivy Communications, Inc. System and method for maintaining timing of synchronization messages over a reverse link of a CDMA wireless communication system
US9525923B2 (en) 1997-12-17 2016-12-20 Intel Corporation Multi-detection of heartbeat to reduce error probability
US7394791B2 (en) 1997-12-17 2008-07-01 Interdigital Technology Corporation Multi-detection of heartbeat to reduce error probability
US6222832B1 (en) 1998-06-01 2001-04-24 Tantivy Communications, Inc. Fast Acquisition of traffic channels for a highly variable data rate reverse link of a CDMA wireless communication system
US7496072B2 (en) 1997-12-17 2009-02-24 Interdigital Technology Corporation System and method for controlling signal strength over a reverse link of a CDMA wireless communication system
US8134980B2 (en) 1998-06-01 2012-03-13 Ipr Licensing, Inc. Transmittal of heartbeat signal at a lower level than heartbeat request
US7773566B2 (en) 1998-06-01 2010-08-10 Tantivy Communications, Inc. System and method for maintaining timing of synchronization messages over a reverse link of a CDMA wireless communication system
US6526034B1 (en) 1999-09-21 2003-02-25 Tantivy Communications, Inc. Dual mode subscriber unit for short range, high rate and long range, lower rate data communications
AU3673001A (en) 2000-02-07 2001-08-14 Tantivy Communications, Inc. Minimal maintenance link to support synchronization
US8155096B1 (en) 2000-12-01 2012-04-10 Ipr Licensing Inc. Antenna control system and method
US7551663B1 (en) 2001-02-01 2009-06-23 Ipr Licensing, Inc. Use of correlation combination to achieve channel detection
US6954448B2 (en) 2001-02-01 2005-10-11 Ipr Licensing, Inc. Alternate channel for carrying selected message types
WO2002064085A2 (en) * 2001-02-02 2002-08-22 Ortho-Mcneil Pharmaceutical, Inc. Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin
EP2479904B1 (en) 2001-06-13 2017-02-15 Intel Corporation Apparatuses for transmittal of heartbeat signal at a lower level than heartbeat request
DE60332358D1 (de) * 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
EP1578394A4 (en) * 2002-12-31 2011-02-23 Nektar Therapeutics ANTIBODY PARTICLES AND COMPOSITIONS
WO2005054301A1 (ja) 2003-11-14 2005-06-16 Chugai Seiyaku Kabushiki Kaisha 架橋多糖微粒子およびその製造方法
MX2007007590A (es) 2004-12-22 2007-12-10 Ambrx Inc Composiciones que contienen, metodos que involucran y usos de aminoacidos no naturales y polipeptidos.
EP2284191A3 (en) 2004-12-22 2011-07-20 Ambrx, Inc. Process for the preparation of hGH
US20090018029A1 (en) 2005-11-16 2009-01-15 Ambrx, Inc. Methods and Compositions Comprising Non-Natural Amino Acids
DK2615108T3 (en) 2006-09-08 2017-01-30 Ambrx Inc Modified human plasma polypeptide or fc scaffolds and their applications
KR101248252B1 (ko) 2006-11-28 2013-03-27 한올바이오파마주식회사 변형된 에리스로포이에틴 폴리펩티드와 이의 치료용 용도
PL2068909T3 (pl) 2007-03-30 2012-09-28 Ambrx Inc Modyfikowane polipeptydy fgf-21 i ich zastosowanie
EP2076533B1 (en) 2007-05-02 2014-10-08 Ambrx, Inc. Modified interferon beta polypeptides and their uses
BRPI0907186A2 (pt) * 2008-01-15 2015-07-14 Abbott Gmbh & Co Kg Composições proteicas pulverizadas e métodos para sua produção
PL2318029T3 (pl) 2008-07-23 2018-03-30 Elanco Us Inc. Zmodyfikowane polipeptydy bydlęcego G-CSF i ich zastosowania
PT104350A (pt) 2009-01-23 2010-07-23 Hovione Farmaci Ncia S A Processo de isolamento de tigeciclina
BR112012015461A2 (pt) 2009-12-21 2017-01-10 Ambrx Inc polipeptídeos de somatotropina boviina modificados e seus usos
US20120283172A1 (en) 2009-12-21 2012-11-08 Ambrx, Inc. Modified porcine somatotropin polypeptides and their uses
AR083006A1 (es) 2010-09-23 2013-01-23 Lilly Co Eli Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
ES2645769T3 (es) 2011-01-05 2017-12-07 Hospira, Inc. Secado por pulverización de la vancomicina
WO2013126552A1 (en) 2012-02-21 2013-08-29 Auburn University Buprenorphine nanoparticle composition and methods thereof
CN104043104B (zh) 2013-03-15 2018-07-10 浙江创新生物有限公司 含盐酸万古霉素的喷雾干粉及其工业化制备方法
CN107108710B (zh) 2014-10-24 2022-02-15 百时美施贵宝公司 修饰的fgf-21多肽及其用途
CN104984323B (zh) * 2015-06-12 2018-05-01 北京四环生物制药有限公司 注射用重组人促红素冻干粉针剂
CN105311624A (zh) * 2015-11-23 2016-02-10 哈药集团生物工程有限公司 一种含有重组人促红素的药物组合物
DK3849614T3 (da) 2018-09-11 2024-02-26 Ambrx Inc Interleukin-2-polypeptidkonjugater og anvendelser deraf
WO2020082057A1 (en) 2018-10-19 2020-04-23 Ambrx, Inc. Interleukin-10 polypeptide conjugates, dimers thereof, and their uses
AU2020223031B2 (en) 2019-02-12 2024-08-29 Ambrx, Inc. Compositions containing, methods and uses of antibody-TLR agonist conjugates
MX2022011163A (es) 2020-03-11 2022-10-18 Ambrx Inc Conjugados de polipeptidos de interleucina-2 y sus usos.
AU2021327396A1 (en) 2020-08-20 2023-03-23 Ambrx, Inc. Antibody-TLR agonist conjugates, methods and uses thereof
EP4313163A1 (en) 2021-04-03 2024-02-07 Ambrx, Inc. Anti-her2 antibody-drug conjugates and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57149228A (en) * 1981-03-11 1982-09-14 Ajinomoto Co Inc Novel erythropoietin and its preparation
JPS6197229A (ja) * 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
DE3729863A1 (de) * 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate
GB9001987D0 (en) * 1990-01-29 1990-03-28 Janssen Pharmaceutica Nv Improved cyclodextrin based erythropietin formulation
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin

Also Published As

Publication number Publication date
DK0805822T4 (da) 2011-07-11
JP4039686B2 (ja) 2008-01-30
ZA9510708B (en) 1997-06-17
PT805822E (pt) 2004-08-31
CA2207615C (en) 2010-12-14
AU697287B2 (en) 1998-10-01
NZ298981A (en) 1999-11-29
EP0805822A1 (en) 1997-11-12
ATE265468T1 (de) 2004-05-15
IL116085A0 (en) 1996-01-31
EP0805822B2 (en) 2011-06-15
TW425287B (en) 2001-03-11
DE69532970D1 (en) 2004-06-03
DE69532970T3 (de) 2012-02-09
NO972725L (no) 1997-08-06
ES2219672T3 (es) 2004-12-01
CN1175261A (zh) 1998-03-04
US6235710B1 (en) 2001-05-22
MX9704504A (es) 1998-06-30
FI972557L (fi) 1997-08-14
CA2207615A1 (en) 1996-06-20
DK0805822T3 (da) 2004-08-16
FI119723B (fi) 2009-02-27
WO1996018647A1 (en) 1996-06-20
FI972557A0 (fi) 1997-06-16
HUT77811A (hu) 1998-08-28
AU4471396A (en) 1996-07-03
IL116085A (en) 1999-12-31
US6001800A (en) 1999-12-14
EP0805822B1 (en) 2004-04-28
CN1117762C (zh) 2003-08-13
DE69532970T2 (de) 2005-06-09
JPH10511087A (ja) 1998-10-27
ES2219672T5 (es) 2011-09-26
NO319895B1 (no) 2005-09-26
HU222370B1 (hu) 2003-06-28

Similar Documents

Publication Publication Date Title
NO972725D0 (no) Spraytörket erytroprotein
IS4963A (is) Setnar 6,5-heteró-bísýklískar afleiður
DE69110416D1 (de) Thermisches Sprühpulver.
ZA961291B (en) Naphthyl compounds, intermediates, compositions, and methods.
FI900752A0 (fi) Maskin foer automatisk montering av en elastisk taetning, i synnerhet en yttre taetning, i en foensterspringa.
FI906340A7 (fi) Flerkanalanordning foer maetning av svaga, lokal- och tidsberoende magnetfaelt.
FI922178L (fi) Kretssystem, foer koppling av rf-signaler.
FI915303A0 (fi) Foerpackningspaose, isynnerhet av plastfolie.
FI895678A7 (fi) Faestanordning foer faestning av skivor, saerskilt ljusreklamskivor.
DE69010041D1 (de) Pulverbeschichtungen.
AU2316897A (en) Cyclic imido-1,3,5-triazine crosslinking agents
FI894435A7 (fi) Integrerad, av driftsspaenning en oberoende dynamisk amplitudbegraensare.
MX9603516A (es) Derivados de oxima y su uso como pesticidas.
NO904034L (no) Fremgangsmaate for fremstilling av 1-etylfenoksatiin-10,10-dioksyd.
FI915740A0 (fi) Tobaksprodukt foer sjaelvframstaellning av en cigarrett, speciellt en filtercigarrett.
NO902138D0 (no) Fremgangsmaate for pulverbelegging.
FI920958A0 (fi) Anordning foer breddstraeckning av loepande materialbanor, speciellt pappersbanor.
ZA983781B (en) Process for the preparation of 1,1,1,3,3-pentachlorobutane.
ES1026567Y (es) Protesis peneana, mejorada.
KR920006582U (ko) 개스등
ES1029056Y (es) Hombrera para prendas de vestir.
FI895722A0 (fi) Medel foer behandling av sjukdomar i hjaertats kretslopp, speciellt arrytmi.
MX9604978A (es) Polvos de acifluorfeno solido altamente concentrados, y procesos para fabricar polvos de acifluorfeno solido en forma seca.
ES1030734Y (es) Tapon-llavero, perfeccionado.
FI941011A0 (fi) Balningspress, saerskilt foer balning av avfallspapplaodor o.d. returavfall

Legal Events

Date Code Title Description
MK1K Patent expired